Continuing diarrhoea after ten days of oral metronidazole or oral vancomycin for presumed, hospital-acquired Clostridium difficile colitis in elderly hospital patients

Journal of Hospital Infection

Volumn 74, Issue 4, 2010, Pages 403-405

  Parks, T ^a   Wallis, S ^b   Wilson, J ^b   Gkrania Klotsas, E ^b   Nicholl, C ^b  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; METRONIDAZOLE; VANCOMYCIN; ALBUMINOID; ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; CREATININE;

ABDOMINAL RADIOGRAPHY; AGED HOSPITAL PATIENT; ANTIBIOTIC THERAPY; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE ASSOCIATION; HOSPITAL ACQUIRED CLOSTRIDIUM DIFFICILE COLITIS; HUMAN; LETTER; LOWER RESPIRATORY TRACT INFECTION; MEDICAL RECORD REVIEW; PERFORATION; PREDICTIVE VALUE; RECURRENT DISEASE; TOXIC MEGACOLON; URINARY TRACT INFECTION; AGED; BLOOD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTION; CROSS INFECTION; FEMALE; HOSPITAL; ISOLATION AND PURIFICATION; LEUKOCYTE COUNT; MALE; MICROBIOLOGY; TIME; UNITED KINGDOM;

AGED, 80 AND OVER; ALBUMINS; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CREATININE; CROSS INFECTION; DIARRHEA; FEMALE; GREAT BRITAIN; HOSPITALS; HUMANS; LEUKOCYTE COUNT; MALE; METRONIDAZOLE; TIME FACTORS; VANCOMYCIN;

EID: 77950964557     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.11.002     Document Type: Letter

References (7)

1. Louie T.J., Peppe J., Watt C.K., et al. Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis 2006, 43:411-420.
2. Musher D.M., Logan N., Bressler A.M., Johnson D.P., Rossignol J.F. Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. Clin Infect Dis 2009, 48:e41-e46.
3. Wullt M., Odenholt I. A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea. J Antimicrob Chemother 2004, 54:211-216.
4. Zar F., Bakkanagari S., Moorthi K., Davis M. A Comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007, 45:302-307.
5. Planche T., Aghaizu A., Holliman R., et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2008, 8:777-784.
6. McFarland L.V., Mulligan M.E., Kwok R.Y., et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989, 320:204-210.
7. Bartlett J.G., Gerding D.N. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008, 46:S12-S18.